Baxter International Inc. (BAX) reported data which includes the perceptions of more than 500 healthcare providers and patients regarding the benefits associated with advanced automated peritoneal dialysis (APD) cyclers with remote monitoring capabilities of home patients. The data were presented at the 52nd Congress of the European Renal Association and European Dialysis and Transplant Association.

The APD cycler study compared the importance and utility of a cycler with remote monitoring features to a cycler without remote monitoring capability. Of those surveyed, 86 percent of the healthcare providers agreed an APD cycler with remote patient monitoring capabilities will provide them more confidence and control when managing peritoneal dialysis patients.

The company also presented several abstracts supporting cost-effectiveness and utility of High Dose Hemodialysis. In an analysis of High Dose HD completed in the United Kingdom, Netherlands and France, High Dose HD at home was found to be cost-effective when compared to conventional in-center HD with the current reimbursement levels. However, High Dose HD when performed in-center versus in-center HD was not cost-effective in France or the UK.

by RTT Staff Writer

For comments and feedback: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Business News

...